Health & Biotech
Q&A: Immutep’s CEO on improving lung cancer survival, and where to next after trial success
ASX Health Stocks: Althea’s cannabis oil approved for reimbursement in Ireland, Imugene begins Phase 1 trial
China’s Silk Road for health and wellness is now even more of a two-way street with Australia
ASX Health Stocks: Recce moves forward in Phase 1/2 study; EMV unveils Gen 2 helmet scanner for ambulance
EZZ forges partnership with high-end travel retailer amid resurgence of Chinese Visitors to Australia
ASX Health Stocks: Chimeric leaps 65pc on Phase1A results, Immutep over 12pc on Phase 2
Melodiol’s Canadian subsidiary Mernova on track for highest ever monthly revenue in October
InteliCare (ASX:ICR) enters healthcare sector announcing Remote Patient Monitoring pilot with leading cancer center
Share and option holders in early counting overwhelmingly supporting Incannex’s move to redomicile to US with sole NASDAQ listing
ASX Health Stocks: Telix tumbles 17pc, Emyria to import MDMA after approval in Canada
Bioxyne subsidiary imports $3.2million of premium quality cannabis flower into Australia
Check Up: Why Goldman Sachs won’t change its ratings on 3 ASX stocks despite Ozempic-driven selloff
Paradigm jumps 20pc on positive Phase 2 trial osteoarthritis results, including ‘notable increase’ in cartilage thickness
Groundbreaking: This drug could be ‘significantly effective’ at treating brain damage in newborns
Prescient prepares to unveil Phase 1b cancer trial findings at world’s largest haematology conference
ASX Health Stocks: Noxopharm jumps +50pc on mRNA vaccine results; Starpharma +25pc on Phase 2 study
Melodiol marks another record revenue quarter with $7.5m of unaudited sales, up 265% on the PCP
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
